ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,629,019 | +38.7% | 54,355 | -5.2% | 0.31% | +24.7% |
| Q3 2023 | $1,174,425 | +6.9% | 57,317 | +3.7% | 0.25% | +14.1% |
| Q2 2023 | $1,098,453 | +20.4% | 55,282 | +3.8% | 0.22% | -16.3% |
| Q1 2023 | $912,566 | -28.3% | 53,273 | -18.1% | 0.26% | -78.7% |
| Q4 2022 | $1,272,226 | +20.0% | 65,009 | -2.1% | 1.23% | +26.8% |
| Q3 2022 | $1,060,000 | +4.4% | 66,410 | -9.9% | 0.97% | +26.0% |
| Q2 2022 | $1,015,000 | -14.8% | 73,743 | -1.9% | 0.77% | +37.4% |
| Q1 2022 | $1,192,000 | -38.2% | 75,177 | -14.9% | 0.56% | -19.9% |
| Q4 2021 | $1,929,000 | – | 88,385 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |